P

Inventor

ALONSO ROBERT

US18 patents
⚠️ This page may combine multiple inventors who share the name “ALONSO ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MITOCHON PHARMACEUTICALS INC

6 patents
US10220006B2Mar 5, 2019

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

MITOCHON PHARMACEUTICALS INC4 citations81
US9974755B2May 22, 2018

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

MITOCHON PHARMACEUTICALS INC9 citations81
US10864173B2Dec 15, 2020

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

MITOCHON PHARMACEUTICALS INC2 citations70
US10548900B2Feb 4, 2020

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

MITOCHON PHARMACEUTICALS INC1 citations68
US11717497B2Aug 8, 2023

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

MITOCHON PHARMACEUTICALS INC0 citations59
US11406642B2Aug 9, 2022

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

MITOCHON PHARMACEUTICALS INC0 citations58

ALONSO ROBERT

5 patents
US8501819B2Aug 6, 2013

Stabilized compositions of volatile alkylating agents and methods of using thereof

ALONSO ROBERT1 citations60
US8450375B2May 28, 2013

Stabilized compositions of volatile alkylating agents and methods of using thereof

ALONSO ROBERT1 citations59
US8501817B2Aug 6, 2013

Stabilized compositions of alkylating agents and methods of using same

ALONSO ROBERT2 citations55
US8501818B2Aug 6, 2013

Stabilized compositions of alkylating agents and methods of using same

ALONSO ROBERT1 citations49
US10744174B1Aug 18, 2020

Composition(s) and method(s) for topically treating pain

ALONSO ROBERT0 citations40

ACTELION PHARMACEUTICALS LTD

2 patents
US8664278B2Mar 4, 2014

Stabilized compositions of volatile alkylating agents and methods of using thereof

ACTELION PHARMACEUTICALS LTD3 citations72
US9382191B2Jul 5, 2016

Stabilized compositions of volatile alkylating agents and methods of using thereof

ACTELION PHARMACEUTICALS LTD0 citations51

YAUPON THERAPEUTICS INC

2 patents
US7872050B2Jan 18, 2011

Stabilized compositions of volatile alkylating agents and methods of using thereof

YAUPON THERAPEUTICS INC3 citations70
US7838564B2Nov 23, 2010

Stabilized compositions of volatile alkylating agents and methods of using thereof

YAUPON THERAPEUTICS INC5 citations70

PEDICIS RES LLC

2 patents
US11833161B2Dec 5, 2023

Compositions and methods for treatment of skin infections

PEDICIS RES LLC0 citations50
US11504384B1Nov 22, 2022

Compositions and methods for treatment of skin infections

PEDICIS RES LLC1 citations50

MITOCHON PHARMACEUTICALS LLC

1 patent
US9763896B2Sep 19, 2017

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

MITOCHON PHARMACEUTICALS LLC5 citations77